Qube Research & Technologies (QRT)
TECX

Qube Research & Technologies (QRT)’s Tectonic Therapeutic TECX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-47,105
Closed -$834K – 4064
2025
Q1 		$834K Buy
47,105
+17,348
+58% +$565K ﹤0.01% 2341
2024
Q4 		$1.37M Buy
+29,757
New +$1.26M ﹤0.01% 2037
2022
Q4 		– Sell
-2,577
Closed -$20K – 3082
2022
Q3 		$20K Sell
2,577
-357
-12% -$3.96K ﹤0.01% 2302
2022
Q2 		$32K Buy
+2,934
New +$34.6K ﹤0.01% 2200

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Qube Research & Technologies (QRT)'s TECX Position: Q2 2025 in Review

Qube Research & Technologies (QRT) sold out of Tectonic Therapeutic (TECX) in Q2 2025, closing a stake of 47,105 shares — an estimated $834K sold.

Qube Research & Technologies (QRT) first reported a position in TECX in Q2 2022 and held it in 4 quarters. The position peaked at $1.37M in Q4 2024. 82 funds tracked by Wall St. Rank hold TECX as of Q2 2025.

  • Qube Research & Technologies (QRT) reported no remaining Tectonic Therapeutic position as of Q2 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 47,105 Tectonic Therapeutic shares in Q2 2025, an estimated $834K.
  • Qube Research & Technologies (QRT) first reported a position in Tectonic Therapeutic in Q2 2022 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s Tectonic Therapeutic position peaked at $1.37M in Q4 2024.
  • 82 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2025, filed 14 Aug 2025.